Caris Life Sciences, Inc. (CAI) is in Healthcare, Biotechnology, based in United States, listed on NasdaqGS. Market cap 7.77B USD. 52-week range 14.19 to 33.65 USD. Trailing P/E 16.3. Data as of 2026-10-09.
Caris Life Sciences, Inc., an artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally. It develops and commercializes solutions to transform healthcare using molecular information, and artificial intelligence/machine learning algorithms. The company's molecular intelligence product portfolio includes MI Profile Platform, a whole exome sequencing (WES)/ whole transcriptome sequencing (WTS) tissue-based molecular profiling solutions; ...